Skip to Content

GS LHF 75 mg (Tafinlar 75 mg)

Generic Name: dabrafenib

Pill with imprint GS LHF 75 mg is Pink, Capsule-shape and has been identified as Tafinlar 75 mg. It is supplied by GlaxoSmithKline.

Tafinlar is used in the treatment of melanoma, metastatic; thyroid cancer; non-small cell lung cancer and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Tafinlar 75 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GS LHF 75 mg

Tafinlar 75 mg GS LHF 75 mg

Tafinlar

Generic Name:
dabrafenib
Imprint:
GS LHF 75 mg
Strength:
75 mg
Color:
Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
GlaxoSmithKline
National Drug Code (NDC):
00173-0847

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide